Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Eli Lilly And Company (DE:LLY)
:LLY
LLY Stock Chart & Stats
Day’s Range― - ―
52-Week Range€657.50 - €885.30
Previous CloseN/A
Volume143.00
Average Volume (3M)3.30K
Market Cap
€791.11B
Enterprise Value€829.46B
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)76.9
Beta0.15
Next Earnings
May 01, 2025EPS Estimate
4.49Last Dividend Ex-Date
Feb 14, 2025Dividend Yield0.59%
Share Statistics
EPS (TTM)10.89
Shares Outstanding948,170,000
10 Day Avg. Volume2,502
30 Day Avg. Volume3,296
Standard Deviation0.09
R-Squared0.00411
Alpha0.04
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)18.38
Price to Cash Flow (P/CF)83.70
P/FCF Ratio211.70
Enterprise Value/Market Cap1.05
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit22.65
Enterprise Value/Ebitda53.07
Forecast
1Y Price Target
€970.75Price Target Upside13.66% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering17
---
Bulls Say, Bears Say
Bulls Say
Drug DevelopmentPhase 3 trials from oral weight loss drug Orforglipron expected to boost Lilly's share price.
Market ExpansionMounjaro has been successfully launched in all major European markets and is expanding in China.
Bears Say
Pricing RisksLilly saw volatile share price movements due to Biden proposing Medicare and Medicaid coverage of obesity drugs, which could put Tirzepatide sales at risk of harsh price cuts in the US.
---
Options Prices
Currently, No data available
---
Ownership Overview
10.34% Insiders
22.57% Mutual Funds
25.88% Other Institutional Investors
25.34% Public Companies and Individual Investors
LLY FAQ
What was Eli Lilly And Company’s price range in the past 12 months?
Eli Lilly And Company lowest stock price was €657.50 and its highest was €885.30 in the past 12 months.
What is Eli Lilly And Company’s market cap?
Eli Lilly And Company’s market cap is €791.11B.
When is Eli Lilly And Company’s upcoming earnings report date?
Eli Lilly And Company’s upcoming earnings report date is May 01, 2025 which is in 67 days.
How were Eli Lilly And Company’s earnings last quarter?
Eli Lilly And Company released its earnings results on Feb 06, 2025. The company reported €5.093 earnings per share for the quarter, beating the consensus estimate of €4.83 by €0.263.
Is Eli Lilly And Company overvalued?
According to Wall Street analysts Eli Lilly And Company’s price is currently Undervalued.
Does Eli Lilly And Company pay dividends?
Eli Lilly And Company pays a Quarterly dividend of €5.157 which represents an annual dividend yield of 0.59%. See more information on Eli Lilly And Company dividends here
What is Eli Lilly And Company’s EPS estimate?
Eli Lilly And Company’s EPS estimate is 4.49.
How many shares outstanding does Eli Lilly And Company have?
Eli Lilly And Company has 948,170,000 shares outstanding.
What happened to Eli Lilly And Company’s price movement after its last earnings report?
Eli Lilly And Company reported an EPS of €5.093 in its last earnings report, beating expectations of €4.83. Following the earnings report the stock price went up 5.851%.
Which hedge fund is a major shareholder of Eli Lilly And Company?
Currently, no hedge funds are holding shares in DE:LLY
---
Eli Lilly & Co Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
€970.75 (13.66% Upside)
€970.75 (13.66% Upside)
Blogger Sentiment
Bullish
DE:LLY Sentiment 70%
Sector Average 70%
Sector Average 70%
Insider Transactions
Sold Shares
Worth $236.4M over
the Last 3 Months
the Last 3 Months
News Sentiment
Very Bullish
Bullish news 99%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Negative
20 days / 200 days
Momentum
17.89%
12-Months-Change
Fundamentals
Return on Equity
65.75%
Trailing 12-Months
Asset Growth
30.55%
Trailing 12-Months
Company Description
Eli Lilly And Company
Founded in 1876, Eli Lilly & Co. is a leading healthcare company that manufactures and sells pharmaceutical products worldwide. The company is headquartered in Indianapolis, Indiana.
---
LLY Company Deck
---
LLY Earnings Call
Q4 2025
0:00 / 0:00
Earnings Call Sentiment|Positive
The earnings call highlighted significant revenue growth and successful product launches, underpinned by strategic investments and advancements in the pipeline. However, challenges such as pricing pressures, a decline in Trulicity revenue, and supply constraints in certain regions tempered the overall positive outlook.Read More>---
LLY Revenue Breakdown
67.44% U.S.
15.36% Europe
9.48% ROW
4.03% Japan
3.69% China
---
LLY Stock 12 Month Forecast
Average Price Target
€970.75
▲(13.66% Upside)
Technical Analysis
Best Analysts Covering LLY
1 Year
1 Year Success Rate
33/35 ratings generated profit
1 Year Average Return
+40.04%
reiterated a buy rating last month
Copying Chris Schott's trades and holding each position for 1 Year would result in 94.29% of your transactions generating a profit, with an average return of +40.04% per trade.
---